Digestives & Intestinal Remedies - India

  • India
  • In 2024, the Digestives & Intestinal Remedies market market in India is projected to generate a revenue of US$0.77bn.
  • It is anticipated that the market will experience an annual growth rate of 6.60% (CAGR 2024-2029).
  • Comparing globally, in China leads the market with a revenue of US$4,408.00m in 2024.
  • When considering the total population, the per person revenue in India is estimated to be US$0.54 in 2024.
  • India's growing population and increasing awareness of digestive health have led to a surge in demand for digestive and intestinal remedies in the OTC pharmaceutical market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in India has been experiencing significant growth in recent years.

Customer preferences:
Indian consumers are increasingly becoming health-conscious and are seeking natural remedies for digestive issues. This has led to a growing demand for digestive and intestinal remedies that are made from natural ingredients and have minimal side effects. Customers are also looking for products that are easily accessible and affordable.

Trends in the market:
One major trend in the Digestives & Intestinal Remedies market in India is the increasing popularity of herbal and Ayurvedic remedies. Ayurveda, an ancient Indian system of medicine, has gained recognition for its ability to address digestive issues. This has led to the introduction of a wide range of Ayurvedic digestive and intestinal remedies in the market. Additionally, there is a growing trend of consumers opting for probiotic supplements to improve their gut health.

Local special circumstances:
India has a rich tradition of using natural remedies for various ailments, including digestive issues. The country is known for its diverse range of herbs and spices that are used in traditional medicine. This cultural preference for natural remedies has contributed to the growth of the Digestives & Intestinal Remedies market in India. Additionally, the country's large population and increasing disposable income have created a favorable market for digestive and intestinal remedies.

Underlying macroeconomic factors:
India's rapidly growing middle class and rising disposable income levels have played a significant role in the growth of the Digestives & Intestinal Remedies market. As more people have the financial means to prioritize their health and well-being, the demand for digestive and intestinal remedies has increased. Furthermore, the government's initiatives to promote traditional medicine and Ayurveda have also contributed to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in India is experiencing growth due to the increasing health-consciousness among consumers, the popularity of herbal and Ayurvedic remedies, the cultural preference for natural remedies, and the country's favorable macroeconomic factors.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)